Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Voorham, Quirinus J M ^a   Janssen, Jerry ^a   Tijssen, Marianne ^a   Snellenberg, Suzanne ^a   Mongera, Sandra ^a   van Grieken, Nicole C T ^a   Grabsch, Heike ^d   Kliment, Martin ^e   Rembacken, Bjorn J ^f   Mulder, Chris J J ^a   van Engeland, Manon ^b,c   Meijer, Gerrit A ^a   Steenbergen, Renske D M ^a   Carvalho, Beatriz ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e Vitkovice vyzkum a vyvoj technicke aplikace as   (Czech Republic)

^f LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

APC; Colon; CpG island; Epigenetic; Flat adenoma; Hypermethylation; qMSP; Superficial elevated; Wnt signaling pathway

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; POLYPLOIDY; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SOXF TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84890346979     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-603     Document Type: Article

References (42)

1. Muto T, Kamiya J, Sawada T, Konishi F, Sugihara K, Kubota Y, Adachi M, Agawa S, Saito Y, Morioka Y. Small " flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum 1985, 28:847-851. 10.1007/BF02555490, 4053897.
2. Kudo S, Tamura S, Hirota S, Sano Y, Yamano H, Serizawa M, Fukuoka T, Mitsuoka H, Nakajima T, Kusaka H. The problem of de novo colorectal carcinoma. Eur J Cancer 1995, 31A:1118-1120.
3. Kudo S, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van GA, Jung M, Vieth M, Jass JR, Hurlstone PD. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008, 68:S3-S47. 10.1016/j.gie.2008.07.052, 18805238.
4. Bianco MA, Cipolletta L, Rotondano G, Buffoli F, Gizzi G, Tessari F. Prevalence of nonpolypoid colorectal neoplasia: an Italian multicenter observational study. Endoscopy 2010, 42:279-285.
5. Rembacken BJ, Fujii T, Cairns A, Dixon MF, Yoshida S, Chalmers DM, Axon AT. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 2000, 355:1211-1214. 10.1016/S0140-6736(00)02086-9, 10770302.
6. Rondagh EJ, Masclee AA, van der Valk ME, Winkens B, de Bruine AP, Kaltenbach T, Soetikno RM, Sanduleanu S. Nonpolypoid colorectal neoplasms: gender differences in prevalence and malignant potential. Scand J Gastroenterol 2012, 47:80-88. 10.3109/00365521.2011.638395, 22149943.
7. Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, Matsui S, Friedland S. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008, 299:1027-1035. 10.1001/jama.299.9.1027, 18319413.
8. Hurlstone DP, Cross SS, Adam I, Shorthouse AJ, Brown S, Sanders DS, Lobo AJ. A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom. Am J Gastroenterol 2003, 98:2543-2549. 10.1111/j.1572-0241.2003.07679.x, 14638361.
9. Voorham QJM, Rondagh EJA, Knol DL, van Engeland M, Carvalho B, Meijer GA, Sanduleanu S. Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis. Am J Gastroenterol 2013, 108:1042-1056. 10.1038/ajg.2013.126, 23649184.
10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767. 10.1016/0092-8674(90)90186-I, 2188735.
11. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170. 10.1016/S0092-8674(00)81333-1, 8861899.
12. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810. 10.1146/annurev.cellbio.20.010403.113126, 15473860.
13. Voorham QJ, Carvalho B, Spiertz AJ, Claes B, Mongera S, van Grieken NC, Grabsch H, Kliment M, Rembacken B, van de Wiel MA, Quirke P, Mulder CJ, Lambrechts D, van Engeland M, Meijer GA. Comprehensive mutation analysis in colorectal flat adenomas. PLoS One 2012, 7:e41963. 10.1371/journal.pone.0041963, 3407043, 22848674.
14. Voorham QJ, Carvalho B, Spiertz AJ, van Grieken NC, Mongera S, Rondagh EJ, van de Wiel MA, Jordanova ES, Ylstra B, Kliment M, Grabsch H, Rembacken BJ, Arai T, de Bruine AP, Sanduleanu S, Quirke P, Mulder CJ, van Engeland M, Meijer GA. Chromosome 5q loss in colorectal flat adenomas. Clin Cancer Res 2012, 18:4560-4569. 10.1158/1078-0432.CCR-11-2385, 22761468.
15. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?. Nat Rev Cancer 2006, 6:107-116. 10.1038/nrc1799, 16491070.
16. Pinto D, Clevers H. Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res 2005, 306:357-363. 10.1016/j.yexcr.2005.02.022, 15925592.
17. Belshaw NJ, Elliott GO, Foxall RJ, Dainty JR, Pal N, Coupe A, Garg D, Bradburn DM, Mathers JC, Johnson IT. Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa. Br J Cancer 2008, 99:136-142. 10.1038/sj.bjc.6604432, 2453007, 18542073.
18. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116:2627-2634. 10.1242/jcs.00623, 12775774.
19. Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006, 12:7113-7117.
20. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, Sonoda T, Mori M, Imai K, Tokino T, Shinomura Y. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 2007, 28:2459-2466. 10.1093/carcin/bgm178, 17675336.
21. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002, 31:141-149. 10.1038/ng892, 11992124.
22. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004, 36:417-422. 10.1038/ng1330, 15034581.
23. Zhang W, Glockner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van NL, Herman JG, Schuebel KE, Watkins DN, Ahuja N, Baylin SB. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 2008, 68:2764-2772. 10.1158/0008-5472.CAN-07-6349, 2823123, 18413743.
24. Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE. Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 1999, 4:487-498. 10.1016/S1097-2765(00)80200-2, 10549281.
25. van der Meide WF, Snellenberg S, Meijer CJ, Baalbergen A, Helmerhorst TJ, van der Sluis WB, Snijders PJ, Steenbergen RD. Promoter methylation analysis of WNT/beta-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. Gynecol Oncol 2011, 123:116-122. 10.1016/j.ygyno.2011.06.015, 21726894.
26. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004, 96:294-305. 10.1093/jnci/djh031, 14970278.
27. Urban O, Vitek P, Fojtik P, Kliment M, Janik D, Chalupa J, Albin A. Laterally spreading tumors-experience based on 138 consecutive cases. Hepatogastroenterology 2008, 55:351-355.
28. Endoscopic Classification Review Group The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003, 58:S3-S43. 10.1016/S0016-5107(03)02159-X, 14652541, Endoscopic Classification Review Group.
29. Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den Ijssel PR, Snijders AM, Albertson DG, Coffa J, Schouten JP, van de Wiel MA, Meijer CJ, Steenbergen RD. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006, 209:220-230. 10.1002/path.1966, 16538612.
30. Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ, Snijders PJ, Steenbergen RD. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 2009, 219:327-336. 10.1002/path.2598, 19662663.
31. Harden SV, Guo Z, Epstein JI, Sidransky D. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 2003, 169:1138-1142. 10.1097/01.ju.0000049627.90307.4d, 12576869.
32. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
33. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995, 310:170. 10.1136/bmj.310.6973.170, 2548561, 7833759.
34. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49:1373-1379. 10.1016/S0895-4356(96)00236-3, 8970487.
35. Nosho K, Yamamoto H, Takahashi T, Mikami M, Taniguchi H, Miyamoto N, Adachi Y, Arimura Y, Itoh F, Imai K, Shinomura Y. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers. Carcinogenesis 2007, 28:1364-1370. 10.1093/carcin/bgl246, 17183069.
36. Derks S, Postma C, Moerkerk PT, van den Bosch SM, Carvalho B, Hermsen MA, Giaretti W, Herman JG, Weijenberg MP, de Bruine AP, Meijer GA, van Engeland M. Promoter methylation precedes chromosomal alterations in colorectal cancer development. Cell Oncol 2006, 28:247-257.
37. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, Garcia JM, Munoz A, Esteller M, Gonzalez-Sancho JM. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 2006, 25:4116-4121. 10.1038/sj.onc.1209439, 16491118.
38. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 2005, 19:877-890. 10.1101/gad.1295405, 15833914.
39. Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors?. Dig Dis 1997, 15:302-311. 10.1159/000171605, 9359018.
40. Iacopetta B. Are there two sides to colorectal cancer?. Int J Cancer 2002, 101:403-408. 10.1002/ijc.10635, 12216066.
41. Koestler DC, Li J, Baron JA, Tsongalis GJ, Butterly LF, Goodrich M, Lesseur C, Karagas MR, Marsit CJ, Moore JH, Andrew AS, Srivastava A. Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon. Mod Pathol 2013, doi: 10.1038/modpathol.2013.104.
42. Rondagh EJ, Bouwens MW, Riedl RG, Winkens B, Rondagh EJ, Bouwens MW, Riedl RG, Winkens B, de Ridder R, Kaltenbach T, Soetikno RM, Masclee AA, Sanduleanu S. Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointest Endosc 2012, 75:1218-1225. 10.1016/j.gie.2012.02.010, 22482917.